Premium Reports
Contact KLAS

Preferences

   Bookmark

Related Series

CMS Payer Interoperability 2022
|
2022

Related Segments

 End chart zoom
CMS Payer Interoperability 2024 CMS Payer Interoperability 2024
* A page refresh may be necessary to see the updated image
Upcoming

CMS Payer Interoperability 2024
How Are Payers Optimizing the Use of Their Solutions beyond Compliance?

author - Tyson Blauer
Author
Tyson Blauer
author - Ruirui Sun
Author
Ruirui Sun
 
May 2024

With the initial goal of meeting CMS requirements (e.g., CMS-9115-F), payer organizations have invested heavily in interoperability solutions to transform data into the FHIR format and provide APIs for member portals and other data exchanges. Still, industry-wide usage among patients for these types of offerings is low, with very few enrolled members asking payers for their medical information. As a result, payers need to determine how to utilize the solutions in a way that maximizes their value, especially as some payers report higher price tags from vendors for the technology to support more use cases. To help payer organizations navigate this field, this report examines the performance of CMS interoperability vendors as well as what current and future use cases are a priority for payers.

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.
author - Carlisa Cramer
Writer
Carlisa Cramer
author - Jess Wallace-Simpson
Designer
Jess Wallace-Simpson
author - Andrew Wright
Project Manager
Andrew Wright

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

Related Segments

​